New Drug-Eluting Balloon Matches Standard Stents in Safety and Effectiveness: SELUTION4ISR Trial
A new drug-eluting balloon (DEB) may offer a safer and equally effective alternative to conventional metallic stents for patients with coronary in-stent restenosis (ISR), according to the results of the SELUTION4ISR Trial.
The international study, led by researchers at Mount Sinai Hospital, New York, presented its findings at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 conference in San Francisco, marking a major advancement in interventional cardiology.
Author summary: New DEB offers safer alternative to metallic stents.
More News
- Windows 11 KB5067036 issue: Task Manager won’t close and duplicates, may hurt performance
- Landry's Explosive Quote That Signals Major Changes at LSU
- The children are starving; God is screaming – Baptist News Global
- Trump’s Gunboat Diplomacy In The Caribbean Targets Maduro’s Venezuela - Black Star News
- Malibu council confronts Fire Rebuild Crisis
- Rob Jetten’s liberals and Geert Wilders’ far right battle to win Dutch election
- Apple stock gets $320 target from BofA ahead of Q4 earnings - 9to5Mac
- Live Nation Venue The Truth Slated for Fall 2026 Opening
- U.S. Gunboat Diplomacy Will Only Embolden China
- Poll: 42% of Americans Approve of Trump’s Job Performance | News